Local treatment for prostate cancer with few metastases
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how well treating the main prostate tumor works for men whose cancer has only spread to a few spots (like bone or lung). It uses a special scan called PSMA-PET to find those spots and aims to see if local treatment helps control the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your prostate cancer has spread to a small number of places outside the prostate, found by a PSMA-PET scan.
- You have already had treatment for the main tumor in your prostate (surgery or radiation).
- You have no more than 5 bone spots or 3 lung spots on the scan.
- Your cancer has not spread to organs like the liver or brain.
- You did not receive hormone or other therapy before your first PSMA-PET scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a precise form of radiation (stereotactic body radiotherapy) can control a small number of prostate cancer spots seen on a special scan (PSMA PET/CT). It may help by treating limited metastases while avoiding unnecessary treatment elsewhere.
This Phase 3 trial tests whether treating only a small number of prostate cancer metastases can help people with “oligorecurrent” (limited repeat) prostate cancer. It may reduce cancer activity while avoiding broader whole-body treatment for some patients.
This trial tests a combination of two treatments for men with prostate cancer that has spread to a small number of sites: a radioactive injection (177Lu-PSMA-617) that targets cancer cells, plus hormone-blocking medication. The goal is to control the cancer and delay progression.
This trial is testing whether giving radiation to all spots of cancer that show up on a PSMA PET scan works better than giving radiation only to the main tumor in the prostate. It is for men whose prostate cancer has spread to a few other places (up to 10 spots).
This study tests whether adding a type of high-precision radiation (MDRT) to standard hormone therapy works better for men with prostate cancer that has spread to just a few places. It is for patients who are newly diagnosed and on long-term hormone therapy.
This trial uses a special PET scan (POSLUMA) before and after radiation to see if it helps treat prostate cancer that has spread to a few spots outside the pelvis. It's for men whose cancer still responds to hormone therapy and who have not had widespread spread.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.